Nature Chemical Biology 'Under Review': What Each Status Means

Before the paper reaches external reviewers, a Nature Chemical Biology handling editor consults with the other editors to evaluate whether the chemistry-biology integration warrants Nature Chemical Biology's selective editorial slots. Roughly 80 to 88 percent of submissions are rejected at this stage.

A desk rejection most often means the editors concluded that the work is strong in chemistry but weak in biology (or vice versa), has insufficient interdisciplinary framing, presents narrow specialist contributions without broad chemical biology significance, or packages where the chemistry-biology interface is not genuinely integrated. Common reasons for rejection at Nature Chemical Biology include all four of these patterns.

The Nature Chemical Biology editorial assistant confirms files are complete: manuscript with figures embedded, supplementary information separate, reporting checklists where applicable (ARRIVE for animal work, MIQE for quantitative PCR), Supporting Information with chemistry characterization data (NMR, mass spec) and biology validation data, cover letter directed to the editor (cover letter is the first thing we read at Nature Chemical Biology), conflict-of-interest declarations, ethics-statement documentation, IRB approvals, and data-availability statement.

The primary handling editor reads the paper and evaluates chemistry-biology integration, broad chemical biology significance, methodological rigor, and Nature Portfolio family routing. The editor and the editorial team decide whether or not to send the manuscript out to review.

In parallel with the primary handling editor's read, ambiguous-fit papers are discussed across the Nature Chemical Biology editorial team where peer handling editors and senior editors weigh in on whether the paper would fit better at Nature Chemical Biology or at sister Nature Portfolio titles (Nature Chemistry for chemistry-leaning work, Nature Methods for methodology-focused work, Nature Communications for broader scope). This editorial consultation runs alongside the desk-screen and adds 3 to 7 days to the timeline that is invisible to the author in the portal.

Nature Chemical Biology handling editors typically invite 2 to 3 external reviewers, with reviewer recruitment typically taking 14 to 21 days. The recruitment window can take longer because reviewers with topic-matched chemistry-biology interface expertise (especially across the chemistry-biology boundary, with both chemistry rigor and biology relevance) are scarce.

Once reviewers agree to review, the typical Nature Chemical Biology peer-review cycle lasts 4 to 12 weeks per reviewer. Reviewers are asked to evaluate chemistry-biology integration, broad chemical biology significance, methodological rigor, and reproducibility. Reviewer reports for Nature Chemical Biology tend to be thorough; 2500 to 5000 word reports are typical given the high-stakes editorial decision and chemistry-biology interface complexity.

After reports return, the handling editor synthesizes them. The 2 to 4 month first-decision time applies to papers that reach external peer review.

• Rejection within 1 to 7 days: Administrative issue or immediate scope mismatch.

• Rejection within 7 to 14 days: Handling editor + editorial consultation desk rejection per the 80 to 88 percent figure.

• Still Under Review after 4 weeks: Strong signal. Paper passed the Nature Chemical Biology filter.

• Still Under Review after 12 weeks: Reviewer-recruitment or reviewer-report delay. A polite inquiry via the Manuscript Tracking System is appropriate.

• Status changes to "Decision Pending": Reports are in; expect a decision within 2 to 3 weeks.

This is the most common anxiety we hear from Nature Chemical Biology authors during the active editorial window. The honest answer: no, 8 weeks at Under Review puts you in the early-to-middle portion of Nature Chemical Biology's 2 to 4 month first-decision distribution. Reports may still be arriving with the handling editor preparing to synthesize them.

Most reviewer-driven delays come from reviewer-recruitment timing rather than slow reviews because Nature Chemical Biology recruits topic-matched chemistry-biology interface reviewers who are scarce and frequently decline initial invitations.

If the portal still says Under Review at the 12-week mark, the most likely explanation is that one of the assigned reviewers asked for an extension and the handling editor granted it, or that a replacement reviewer is being recruited. This is normal practice at Nature Chemical Biology.

What you should NOT do during the 8-to-12-week window is email the editorial office. Nature Chemical Biology handling editors are managing 30+ active papers; an inquiry at 8 weeks adds friction without accelerating the timeline.

If your Nature Chemical Biology paper is rejected after review, the natural cascade depends on what the reviewers and handling editor cited:

Nature Chemistry is the natural Springer Nature cascade for chemistry-leaning chemical biology papers. Nature Portfolio supports manuscript-transfer with reviewer reports preserved. The Nature Chemistry Manuscript Tracking System at mts-nchem.nature.com handles submission; nchem@nature.com handles publisher-level inquiries.

Nature Methods is the Springer Nature cascade for methodology-focused chemical biology papers.

Nature Communications is the broader-scope Springer Nature cascade for chemical biology papers where the Nature Portfolio scope fits.

Communications Chemistry is the Nature Portfolio open-access cascade for chemistry papers where open-access fits.

JACS is the external ACS chemistry flagship cascade. JACS uses ACS Paragon Plus at ACS journal page; editorial contact jacs@acs.org.

Cell Chemical Biology is the external Cell Press cascade for chemistry-biology integration papers. Cell Press uses Editorial Manager at Editorial Manager submission portal; editorial contact cellchembio@cell.com.

Nature Chemical Biology asks reviewers to evaluate four things specifically. The table below maps each to actionable preparation.

In our pre-submission work with Nature Chemical Biology-targeted manuscripts, three named patterns generate the most consistent reviewer concerns and the most common reasons papers miss the editorial bar or fail the desk screen.

Unbalanced chemistry-biology framing flagged at handling editor screen. When the work is strong in chemistry but weak in biology (or vice versa), Nature Chemical Biology handling editor desk rejection within 7 to 14 days is common. This is an explicit Nature Chemical Biology desk-rejection criterion. The strongest manuscripts demonstrate rigor on both sides of the chemistry-biology interface through matched synthetic characterization, cell or organism validation, controls, and figure logic that makes the bridge visible.

Check whether your Nature Chemical Biology bridge is balanced →

Side-by-side rather than integrated chemistry-biology framing flagged at desk screen. When the chemistry-biology interface is not genuinely integrated, handling editor desk rejection is common. The strongest manuscripts frame the chemistry-biology integration as a unified contribution in the title, abstract, schematic figure, results sequence, and discussion, so reviewers do not see a chemistry paper with biology validation appended at the end.

Check your chemistry-biology integration framing →

Cover-letter framing weakness flagged at desk screen. Editors do read cover letters at Nature Chemical Biology, and the cover letter is the first thing they read. When the cover letter does not name what is genuinely new at the chemistry-biology interface, handling editor desk rejection is common. The strongest cover letters explicitly name the integration novelty, the reader benefit, and the specific evidence package that supports both chemical characterization and biological relevance.

Check your Nature Chemical Biology cover-letter claim →

We have reviewed 50+ manuscripts targeting Nature Chemical Biology, Nature Chemistry, JACS, Cell Chemical Biology, Nature Methods, and Nature Communications. This guide tells you what Nature Chemical Biology editors look for in the status window, while the review tells you whether your paper passes the same chemistry-biology integration, characterization, assay-validation, and cover-letter checks before the handling editor or external reviewers see it. Full Manusights reviews include a 60-day money-back guarantee, and we do not train models on your manuscript.

In the 100-manuscript Manusights sample across chemical-biology, methods, and chemistry targets, Nature Chemical Biology-bound drafts most often failed when the chemistry was publishable and the biology was publishable, but the manuscript did not prove why the two belonged together. Manusights internal analysis identifies this as a recurring failure pattern because the handling editor can often see the side-by-side structure from the abstract, schematic, and first results figure.

Source limitation: official guidance explains Nature Chemical Biology submission policies and reporting requirements, but it cannot diagnose whether your specific chemistry-biology interface is integrated enough for this journal rather than Nature Chemistry, Nature Methods, JACS, or Cell Chemical Biology.

This page was created from Springer Nature's public Nature Chemical Biology editorial policies at Nature Portfolio journal page, Nature Chemical Biology submission guidelines documentation (primary handling editor + editorial consultation model, cover-letter critical importance, chemistry-biology integration as core editorial criterion, 80 to 88 percent desk rejection rate, 2 to 4 month full peer-review window), and Manusights pre-submission review experience with Nature Chemical Biology-targeted manuscripts.

For the chemistry-biology interface landscape beyond Nature Chemical Biology, see Nature Chemistry (chemistry-leaning cascade), Nature Methods (methodology-focused cascade), Nature Communications (broader Nature Portfolio scope), Communications Chemistry (open-access cascade), JACS (broader ACS chemistry), and Cell Chemical Biology (Cell Press chemistry-biology integration).

The choice across these titles depends on whether the central contribution is top-tier chemistry-biology integration (Nature Chemical Biology), chemistry-leaning (Nature Chemistry), methodology-focused (Nature Methods), broader Nature Portfolio (Nature Communications), open-access chemistry (Communications Chemistry), broad ACS chemistry (JACS), or Cell Press chemistry-biology integration (Cell Chemical Biology).

Reviewers at Nature Chemical Biology typically draw from one chemistry specialist and one biology specialist (matched to the chemistry-biology integration framing). Editors screen and triage manuscripts before any reviewer sees them, and preparing a response template that addresses both chemistry and biology reviewer perspectives accelerates revision rounds substantially.

For a pre-upload check of your manuscript against the Nature Chemical Biology chemistry-biology-integration bar before submission, our Nature Chemical Biology pre-submission diagnostic flags the framing and cover-letter weaknesses most likely to surface in reviewer reports.